Shingles vaccine recommended for seniors

updated 1:04 p.m. ET May 15, 2008

WHITEHOUSE STATION, N.J. - Merck & Co. said Thursday the U.S. Centers for Disease Control and Prevention has recommended that adults 60 and over be given the company's shingles vaccine Zostavax.

The CDC's recommendation follows the unanimous recommendation of the agency's Advisory Committee on Immunization.

Shingles, also called herpes zoster, is a painful skin rash that strikes roughly one in four adults who have previously had chickenpox. According to Merck, more than 43 million Americans are at risk for shingles. However, according to a 2007 CDC survey, few adults are vaccinated against the disease.

Don't miss this on msnbc.com Health Never to part: Devoted couples share life, death After breast cancer, weighty battle ahead Body Odd: What's in a wink? It's no secret! Why we love gossip When you are denied insurance

MORE FROM INFECTIOUS DISEASES

Infectious diseases Section Front

Scientists map genomes of malaria parasites Climate change helps spread deadly diseases Natalie Cole on bed rest after Hep C bout Mail carriers to bring drugs in anthrax attack Scientists learn how Listeria attacks the unborn Hospital worker may have exposed babies to TB Vaccine-wary parents spark public health worry Vaccine refusals fuel jump in measles outbreaks Bacteria a big killer in 1918 flu pandemic: study 6 get Legionnaires’ disease in upstate NY; 1 dies Infectious diseases Section Front   Add Infectious diseases headlines to your news reader: